Progyny, Inc. (PGNY): Share Repurchases

Annual figures by period end, from SEC filings.

$81.66M
Year ended 2025-12-31
$230.29M
Trailing 12 months to 2026-06-30
$300.28M2018-12-31: $1.21M2019-12-31: $185.0K2022-12-31: $02023-12-31: $02024-12-31: $300.28M2025-12-31: $81.66M$81.66M
2018-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$81.66M-72.8%2026-02-27, From 2025-01-01
2024-12-31$300.28Mn/a2026-02-27, From 2024-01-01
2023-12-31$0n/a2026-02-27, From 2023-01-01
2022-12-31$0n/a2025-03-03, From 2022-01-01
No annual figure between 2019-12-31 and 2022-12-31.
2019-12-31$185.0K-84.6%2022-03-01, From 2019-01-01
2018-12-31$1.21Mn/a2021-03-01, From 2018-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Services-Misc Health & Allied Services, NEC), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Progyny, Inc. (PGNY)2025-12-31$81.66M-72.8%
Viemed Healthcare, Inc. (VMD)2025-12-31$13.22Mn/a
DaVita Inc. (DVA)2025-12-31$1.31B-5.6%
Cryo Cell International Inc (CCEL)2025-11-30$169.5K-88.1%
BioRestorative Therapies, Inc. (BRTX)2025-12-31$0n/a

Compare PGNY, VMD, DVA, CCEL side by side · Screen every company in Services-Misc Health & Allied Services, NEC ↗